what does a glp-1 do Weight loss drugs – hope or hype? Why are GLP-1 agonists being

Health Canada approves Wegovy for the treatment of adults with obesity

While it is portrayed as a miracle weight loss drug, there is the dark side of its serious side effects like stomach paralysis affecting thousands of people

Furthermore, insurance coverage and clinical guidelines tend to prioritize treatment for higher BMI categories, facilitating greater access to these medications

are obese, with a body mass index (BMI) of 30 or higher

A Narrative Review for Clinical Practice

The effectiveness of GLP-1 therapies depends not only on their pharmacological properties, but on the ability of patients to integrate them into their lives over the long term